ATE212987T1 - Amino substituierte pyrimidinen und triazinen - Google Patents

Amino substituierte pyrimidinen und triazinen

Info

Publication number
ATE212987T1
ATE212987T1 AT96934690T AT96934690T ATE212987T1 AT E212987 T1 ATE212987 T1 AT E212987T1 AT 96934690 T AT96934690 T AT 96934690T AT 96934690 T AT96934690 T AT 96934690T AT E212987 T1 ATE212987 T1 AT E212987T1
Authority
AT
Austria
Prior art keywords
triazines
amino substituted
substituted pyrimidines
pyrimidines
amino
Prior art date
Application number
AT96934690T
Other languages
English (en)
Inventor
Thomas R Webb
Terence J Moran
James R Mccarthy
Original Assignee
Janssen Pharmaceutica Nv
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv, Neurocrine Biosciences Inc filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE212987T1 publication Critical patent/ATE212987T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • C07D239/49Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT96934690T 1995-10-17 1996-10-15 Amino substituierte pyrimidinen und triazinen ATE212987T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US568795P 1995-10-17 1995-10-17
PCT/EP1996/004478 WO1997014684A1 (en) 1995-10-17 1996-10-15 Amino substituted pyrimidines and triazines

Publications (1)

Publication Number Publication Date
ATE212987T1 true ATE212987T1 (de) 2002-02-15

Family

ID=21717189

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96934690T ATE212987T1 (de) 1995-10-17 1996-10-15 Amino substituierte pyrimidinen und triazinen

Country Status (18)

Country Link
US (1) US6288060B1 (de)
EP (1) EP0863882B1 (de)
JP (1) JPH11513678A (de)
KR (1) KR19990045744A (de)
AR (1) AR004221A1 (de)
AT (1) ATE212987T1 (de)
AU (1) AU703096B2 (de)
CA (1) CA2229710A1 (de)
DE (1) DE69619125T2 (de)
DK (1) DK0863882T3 (de)
ES (1) ES2172681T3 (de)
MY (1) MY113945A (de)
NO (1) NO310771B1 (de)
NZ (1) NZ320227A (de)
PT (1) PT863882E (de)
TW (1) TW378206B (de)
WO (1) WO1997014684A1 (de)
ZA (1) ZA968732B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060478A (en) * 1996-07-24 2000-05-09 Dupont Pharmaceuticals Azolo triazines and pyrimidines
US6124289A (en) * 1996-07-24 2000-09-26 Dupont Pharmaceuticals Co. Azolo triazines and pyrimidines
US6191131B1 (en) 1997-07-23 2001-02-20 Dupont Pharmaceuticals Company Azolo triazines and pyrimidines
US6313124B1 (en) 1997-07-23 2001-11-06 Dupont Pharmaceuticals Company Tetrazine bicyclic compounds
US7094782B1 (en) 1996-07-24 2006-08-22 Bristol-Myers Squibb Company Azolo triazines and pyrimidines
DE19837387A1 (de) * 1998-08-18 2000-02-24 Aventis Res & Tech Gmbh & Co 3'-Desoxypentopyranosyl-Nucleinsäure, ihre Herstellung und Verwendung
AU3357700A (en) * 1999-02-16 2000-09-04 E.I. Du Pont De Nemours And Company Phenoxypyrimidine insecticides and acaricides
US6432989B1 (en) 1999-08-27 2002-08-13 Pfizer Inc Use of CRF antagonists to treat circadian rhythm disorders
IL148903A0 (en) 1999-09-30 2002-09-12 Neurogen Corp Certain alkylene diamine-substituted heterocycles
US6525067B1 (en) * 1999-11-23 2003-02-25 Pfizer Inc Substituted heterocyclic derivatives
WO2001062718A1 (en) * 2000-02-25 2001-08-30 Japan Tobacco, Inc. Benzamide derivative and use thereof
JP2004504302A (ja) 2000-07-18 2004-02-12 ニューロジェン・コーポレーション 5−置換2−アリール−4−ピリミジノン
DE60107603T2 (de) 2000-09-19 2005-10-06 Sumitomo Chemical Co. Ltd. Pyrimidinverbindungen und deren verwendung als pestizide
HUP0303038A2 (hu) 2000-09-21 2003-12-29 Bristol-Myers Squibb Co. Szubsztituált azolszármazékok mint kortikotropin releasing faktor inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
US6872827B2 (en) * 2002-04-26 2005-03-29 Chembridge Research Laboratories, Inc. Somatostatin analogue compounds
CA2527079A1 (en) * 2003-05-29 2005-01-06 Synta Pharmaceuticals, Corp. Heterocyclic compounds for preventing and treating disorders associated with excessive bone loss
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2595697B1 (fr) 1986-03-13 1988-07-08 Rousselot Cie Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
FR2692893B1 (fr) 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
RU2153494C2 (ru) 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
TW530047B (en) 1994-06-08 2003-05-01 Pfizer Corticotropin releasing factor antagonists

Also Published As

Publication number Publication date
AU7292996A (en) 1997-05-07
PT863882E (pt) 2002-07-31
AR004221A1 (es) 1998-11-04
AU703096B2 (en) 1999-03-18
JPH11513678A (ja) 1999-11-24
NO310771B1 (no) 2001-08-27
EP0863882A1 (de) 1998-09-16
KR19990045744A (ko) 1999-06-25
ZA968732B (en) 1998-04-16
MY113945A (en) 2005-12-14
NO981623L (no) 1998-06-09
CA2229710A1 (en) 1997-04-24
WO1997014684A1 (en) 1997-04-24
EP0863882B1 (de) 2002-02-06
NO981623D0 (no) 1998-04-08
TW378206B (en) 2000-01-01
DK0863882T3 (da) 2002-05-06
US6288060B1 (en) 2001-09-11
DE69619125T2 (de) 2002-09-26
DE69619125D1 (de) 2002-03-21
NZ320227A (en) 1998-11-25
ES2172681T3 (es) 2002-10-01

Similar Documents

Publication Publication Date Title
DE69738197D1 (de) Azolotriazine und pyrimidine
FI972087A7 (fi) Dihydropyrimidiineja ja niiden käyttöjä
ATE212987T1 (de) Amino substituierte pyrimidinen und triazinen
DE69627188D1 (de) Brille und brillenfassung
DE69828963D1 (de) Wirstoffabgabe und gentherapiesystem
DK0817775T3 (da) Quinazolinderivater
DK0823900T3 (da) Quinazolinderivater
DE69836459D1 (de) Optisches Element und damit versehenes optisches System
DE69637170D1 (de) Zonenbasierte güterordnung und steuersystem
BR9608155A (pt) Amino fenil uracilas substituídas
DE59802439D1 (de) Spiroverbindungen und deren verwendung
ATE186447T1 (de) Zusammensetzung und verwendung
BR9508539A (pt) Derivado de triazina e medicamento
BR9611570A (pt) Derivados de triazina
GB9617322D0 (en) Triazine derivatives and their use
ZA972553B (en) Aryloxy-and arylthio- substituted pyrimidines and triazines and derivatives thereof
DE69830745D1 (de) Raumeinteilungssystem
DE69835007D1 (de) Entkoffeinierte mate-extrakte und deren verwendung
FI974517A7 (fi) Suodatin ja säätöelin
DE59810405D1 (de) Spiroverbindungen und deren verwendung
BR9609671A (pt) Amino uracilas substituídas
NO990264L (no) Azolotriaziner og -pyrimidiner
DE69617576D1 (de) Grundierungszusammensetzung und optischer Gegenstand
PT819690E (pt) 6-tienil e 4-tienil pirimidinas herbicidas
DE69619355D1 (de) Peripheriemodul und Mikroprozessorsystem

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee